Fig. 2From: Potential public health impact of RTS,S malaria candidate vaccine in sub-Saharan Africa: a modelling studyModel validation, incidence of clinical malaria. Incidence of clinical malaria (defined as in Table 1) per child per year over the 18-month follow-up period observed in the control arm of the Phase III trial and predicted by the model in each transmission category in a the 6–12 weeks age group and b the 5–17 months age groupBack to article page